The impact of chronic hepatitis C on health-related quality of life in homeless and marginally housed individuals with HIV

AIDS and Behavior

Volumn 11, Issue 4, 2007, Pages 603-610

  Tsui, Judith I ^a   Bangsberg, David R ^a,b   Ragland, Kathleen ^a   Hall, Christopher S ^b,c   Riley, Elise D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Hepatitis C; HIV; Homelessness; Quality of Life

Indexed keywords

ADULT; ARTICLE; COMMUNITY; CONTROLLED STUDY; EMOTIONAL STABILITY; FEMALE; HEPATITIS C; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SOCIAL STATUS;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; MALE; PREVALENCE; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; VIRAL LOAD;

EID: 34249729886     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-006-9157-8     Document Type: Article

References (36)

1. Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341, 556-562.
2. Bayliss, M. S., Gandek, B., Bungay, K. M., Sugano, D., Hsu, M. A., & Ware, J. E. Jr. (1998). A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Quality of Life Research, 7, 39-55.
3. Call, S. A., Klapow, J. C., Stewart, K. E., Westfall, A. O., Mallinger, A. P., DeMasi, R., et al. (2000). Health-related quality of life and virologic outcomes in an HIV clinic. Quality of Life Research, 9, 977-985.
4. Carrat, F., Bani-Sadr, F., Pol, S., Rosenthal, E., Lunel-Fabiani, F., Benzekri, A., et al. (2004). Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial. Journal of the American Medical Association, 292, 2839-2848.
5. Cheung, R. C., Hanson, A. K., Maganti, K., Keeffe, E. B., & Matsui, S. M. (2002). Viral hepatitis and other infectious diseases in a homeless population. Journal of Clinical Gastroenterology, 34, 476-480.
6. Chung, R. T., Andersen, J., Volberding, P., Robbins, G. K., Liu, T., Sherman, K. E., et al. (2004). Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. New England Journal of Medicine, 351, 451-459.
7. Cordoba, J., Flavia, M., Jacas, C., Sauleda, S., Esteban, J. I., Vargas, V., et al. (2003a). Quality of life and cognitive function in hepatitis C at different stages of liver disease. Journal of Hepatology, 39, 231-238.
8. Cordoba, J., Reyes, J., Esteban, J. I., & Hernandez, J. M. (2003b). Labeling may be an important cause of reduced quality of life in chronic hepatitis C. American Journal of Gastroenterology, 98, 226-227.
9. Culhane, D. P., Gollub, E., Kuhn, R., & Shpaner, M. (2001). The co-occurrence of AIDS and homelessness: Results from the integration of administrative databases for AIDS surveillance and public shelter utilisation in Philadelphia. Journal of Epidemiology and Community Health, 55, 515-520.
10. Fleming, C. A., Craven, D. E., Thornton, D., Tumilty, S., & Nunes, D. (2003). Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: Low eligibility for interferon treatment. Clinical Infectious Diseases, 36, 97-100.
11. Fontana, R. J., Hussain, K. B., Schwartz, S. M., Moyer, C. A., Su, G. L., & Lok, A. S. (2002). Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. Journal of Hepatology, 36, 401-407.
12. Forton, D. M., Taylor-Robinson, S. D., & Thomas, H. C. (2003). Cerebral dysfunction in chronic hepatitis C infection. Journal of Viral Hepatitis, 10, 81-86.
13. Foster, G. R., Goldin, R. D., & Thomas, H. C. (1998). Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology, 27, 209-212.
14. Gallegos-Orozco, J. F., Fuentes, A. P., Gerardo Argueta, J., Perez-Pruna, C., Hinojosa-Becerril, C., Sixtos-Alonso, M. S., et al. (2003). Health-related quality of life and depression in patients with chronic hepatitis C. Archivesof Medical Research, 34, 124-129.
15. Gill, C. J., Griffith, J. L., Jacobson, D., Skinner, S., Gorbach, S. L., & Wilson, I. B. (2002). Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. Journal of Acquired Immune Deficiency Syndrome, 30, 485-492.
16. Hall, C. S., Charlebois, E. D., Hahn, J. A., Moss, A. R., & Bangsberg, D. R. (2004). Hepatitis C virus infection in San Francisco's HIV-infected urban poor. Journal of General Internal Medicine, 19, 357-365.
17. Hays, R. D., Cunningham, W. E., Sherbourne, C. D., Wilson, I. B., Wu, A. W., Cleary, P. D., et al. (2000). Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV Cost and Services Utilization Study. American Journal of Medicine, 108, 714-722.
18. Hays, R. D., & Woolley, J. M. (2000). The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics, 18, 419-423.
19. Hilsabeck, R. C., Hassanein, T. I., Carlson, M. D., Ziegler, E. A., & Perry, W. (2003). Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. Journal- International Neuropsychological Society, 9, 847-854.
20. Hunt, C. M., Dominitz, J. A., Bute, B. P., Waters, B., Blasi, U., & Williams, D. M. (1997). Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life. Digestive Diseases and Sciences, 42, 2482-2486.
21. Kanwal, F., Gralnek, I. M., Hays, R. D., Dulai, G. S., Spiegel, B. M., Bozzette, S., et al. (2005). Impact of chronic viral hepatitis on health-related quality of life in HIV: Results from a nationally representative sample. American Journal of Gastroenterology, 100, 1984-1994.
22. Kramer, L., Bauer, E., Funk, G., Hofer, H., Jessner, W., Steindl-Munda, P., et al. (2002). Subclinical impairment of brain function in chronic hepatitis C infection. Journal of Hepatology, 37, 349-354.
23. Laguno, M., Murillas, J., Blanco, J. L., Martinez, E., Miquel, R., Sanchez-Tapias, J. M., et al. (2004). Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS, 18, F27-F36.
24. McHutchison, J. G., Ware, J. E. Jr., Bayliss, M. S., Pianko, S., Albrecht, J. K., Cort, S., et al. (2001). The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. Journal of Hepatology, 34, 140-147.
25. Nyamathi, A. M., Dixon, E. L., Robbins, W., Smith, C., Wiley, D., Leake, B., et al. (2002). Risk factors for hepatitis C virus infection among homeless adults. Journal of General Internal Medicine, 17, 134-143.
26. Riley, E. D., Bangsberg, D. R., Perry, S., Clark, R. A., Moss, A. R., & Wu, A. W. (2003). Reliability and validity of the SF-36 in HIV-infected homeless and marginally housed individuals. Quality of Life Research, 12, 1051-1058.
27. Robertson, M. J., Clark, R. A., Charlebois, E. D., Tulsky, J., Long, H. L., Bangsberg, D. R., et al. (2004). HIV seroprevalence among homeless and marginally housed adults in San Francisco. American Journal of Public Health, 94, 1207-1217.
28. Rowan, P. J., Tabasi, S., Abdul-Latif, M., Kunik, M. E., & El-Serag, H. B. (2004). Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C. Journal of Clinical Gastroenterology, 38, 530-534.
29. Samsa, G., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics, 15, 141-155.
30. Spiegel, B. M., Younossi, Z. M., Hays, R. D., Revicki, D., Robbins, S., & Kanwal, F. (2005). Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment. Hepatology, 41, 790-800.
31. Sulkowski, M. S., & Thomas, D. L. (2003). Hepatitis C in the HIV-Infected Person. Annals of Internal Medicine, 138, 197-207.
32. Torriani, F. J., Rodriguez-Torres, M., Rockstroh, J. K., Lissen, E., Gonzalez-Garcia, J., Lazzarin, A., et al. (2004). Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. New England Journal of Medicine, 351, 438-450.
33. Vittinghoff, E., Glidden, D. V., Shiboski, S. C., & McCulloch, C. E. (2005). Regression Methods in Biostatistics. New York, NY: Springer (p. 94).
34. Ware, J. E. Jr., Kosinski, M., Bayliss, M. S., McHorney, C. A., Rogers, W. H., & Raczek, A. (1995). Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Medical Care, 33, AS264-AS279.
35. Ware, J. E. Jr., Kosinski, M., & Gandek, B. (2004). SF-36 Health Survey Manual & Interpretation Guide. QualityMetric Incorporated, Lincoln, RI.
36. Wu, A. W., Hays, R. D., Kelly, S., Malitz, F., & Bozzette, S. A. (1997). Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Quality of Life Reserch, 6, 531-554.